SIMILAR EFFECT OF ESOMEPRAZOLE ON UPPER GASTROINTESTINAL SYMPTOMS IN HIGH UPPER GI RISK VERSUS AVERAGE RISK NSAID USERS

(1) Gastroenterology and Hepatology, Radboud University NijmegenMedical Center, Nijmegen, Nether

(2) Gastroenterology and Hepatology, Free University MedicalCenter, Amsterdam, Netherlands

(3) Rheumatology, Free UniversityMedical Center, Amsterdam, Netherlands



This item was part of the Oesophageal, Gastric and Duodenal Disorders III session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A335